This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Rectal Cancer
and you are
between 18 and 75
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to evaluate the effect of intrarectal Amifostine administration on acute radiation-induced rectal toxicity in pre-operative chemo-radiotherapy.

Provided treatments

  • Drug: Amifostine

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01586117. The sponsor of the trial is Chinese Academy of Medical Sciences and it is looking for 40 volunteers for the current phase.
Official trial title:
A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity